These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 16624294)
1. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Kelly MA; Shuaib A; Todd KG Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294 [TBL] [Abstract][Full Text] [Related]
2. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats. Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955 [TBL] [Abstract][Full Text] [Related]
3. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse. Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804 [TBL] [Abstract][Full Text] [Related]
4. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase. Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717 [TBL] [Abstract][Full Text] [Related]
5. Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat. Swann K; Berger J; Sprague SM; Wu Y; Lai Q; Jimenez DF; Barone CM; Ding Y Brain Res; 2007 Jan; 1129(1):26-33. PubMed ID: 17156757 [TBL] [Abstract][Full Text] [Related]
6. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Sumii T; Lo EH Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911 [TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent. Kahles T; Foerch C; Sitzer M; Schroeter M; Steinmetz H; Rami A; Neumann-Haefelin T Vascul Pharmacol; 2005 Oct; 43(4):254-9. PubMed ID: 16185938 [TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model. Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632 [TBL] [Abstract][Full Text] [Related]
9. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats. Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935 [TBL] [Abstract][Full Text] [Related]
10. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia. Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925 [TBL] [Abstract][Full Text] [Related]
11. Early activation of matrix metalloproteinase-9 is associated with blood-brain barrier disruption after photothrombotic cerebral ischemia in rats. Piao MS; Lee JK; Park CS; Ryu HS; Kim SH; Kim HS Acta Neurochir (Wien); 2009 Dec; 151(12):1649-53. PubMed ID: 19551335 [TBL] [Abstract][Full Text] [Related]
12. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. Asahi M; Asahi K; Wang X; Lo EH J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108 [TBL] [Abstract][Full Text] [Related]
13. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats. Copin JC; Gasche Y Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259 [TBL] [Abstract][Full Text] [Related]
14. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046 [TBL] [Abstract][Full Text] [Related]
15. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion. Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961 [TBL] [Abstract][Full Text] [Related]
17. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat. Nagel S; Genius J; Heiland S; Horstmann S; Gardner H; Wagner S Brain Res; 2007 Feb; 1132(1):210-7. PubMed ID: 17184751 [TBL] [Abstract][Full Text] [Related]
18. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217 [TBL] [Abstract][Full Text] [Related]
19. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Liu W; Hendren J; Qin XJ; Liu KJ Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225 [TBL] [Abstract][Full Text] [Related]
20. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke. Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]